Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Effect of met-enkephalin on chromosomal aberrations in the lymphocytes of the peripheral blood of patients with multiple sclerosis.
Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients.
Vision in a Phase 3 Trial of Natalizumab for Multiple Sclerosis: Relation to Disability and Quality of Life.
Longitudinal assessment of immuno-metabolic parameters in multiple sclerosis patients during treatment with glatiramer acetate.
Neuroenhancement through cognitive training and anodal tDCS in multiple sclerosis.
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis.
Leber's hereditary optic neuropathy associated with multiple sclerosis: Harding's syndrome.
Genzyme’s Lemtrada™ approved in Australia for treatment of multiple sclerosis
Editorial for JNV issue on PML.
Effects of functional electrical stimulation on gait function and quality of life for people with multiple sclerosis taking dalfampridine.
Central Nervous System Herpes Simplex and Varicella-Zoster Virus Infections in Natalizumab-Treated Patients.
Multiple sclerosis susceptibility genes: associations with relapse severity and recovery.
Altered microRNA expression in B lymphocytes in multiple sclerosis: Towards a better understanding of treatment effects.
[A comparison analysis of the use of intravenous β-interferon-1a 30 mcg and subcutaneous β-interferon-1a 44 mcg in routine clinical practice of treatment in patients with multiple sclerosis].
Galectin-1 for neuroprotection?
Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod.
Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 mg GA Depot in Subjects With RRMS
Natalizumab affects the T-cell receptor repertoire in patients with multiple sclerosis.
Recommendations for the clinical use of motor evoked potentials in multiple sclerosis.
Country, Sex, EDSS Change and Therapy Choice Independently Predict Treatment Discontinuation in Multiple Sclerosis and Clinically Isolated Syndrome.
The epidemiology of multiple sclerosis in Latin America and the Caribbean: a systematic review.
Calcitriol Modulates the CD46 Pathway in T Cells.
Amiloride Clinical Trial In Optic Neuritis (ACTION)
Teva Presents New Data Which Demonstrate Reduction of Injection-Related Adverse Events with the Less Frequent Dosing of Three-times-a-week COPAXONE® (glatiramer acetate injection) 40 mg Compared to Daily COPAXONE® 20 mg
Assessment of sphingosine-1-phosphate receptor expression and associated intracellular signaling cascades in primary cells of the human central nervous system.

Pages